Clinical Trial Update: A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase Ib/IIa clinical trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of oral Ecnoglutide in Chinese participants wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Ecnoglutide (ecnoglutide)

Snippet

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. | Conditions: Overweight and/or Obesity, Weight Management | Phase 1, Phase 2 | Status: RECRUITING